跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Lorfast - Philippines FDA Drug Approval Details
Approvals
/
Philippines FDA
/
Lorfast
Approved
STANDARD
Lorfast
Cadila Healthcare Limited
🇵🇭 Food and Drug Administration - Philippines
Approval Date
Jul 14, 2025
Approval ID
9e350ea3186ec256
Company
Cadila Healthcare Limited
Type
Standard
Approval Details
Approval Id
9e350ea3186ec256
Drug Approval Philippines Name
Lorfast
Product Name
Lorfast
Registration Number
DRP-3834
Brand Name
Lorfast
Generic Name
Loratadine
Dosage Form
Tablet
Dosage Strength
10 mg
Manufacturer
Cadila Healthcare Limited
Importer
Ambica International Trading Corp.
Distributor
Ambica International Trading Corp.
Company Detail Path
/organization/cadila-healthcare-ltd
Issuance Date
23 February 2024
Expiry Date
13 December 2029
Pharmacologic Category
Antihistamine
Classification
Over-The-Counter (OTC)
Active Ingredients
Approved
Quick Info
Agency
Philippines FDA
Country
🇵🇭
Approval Date
Jul 14, 2025
Approval ID
9e350ea3186ec256
Type
Standard
Back to Philippines FDA Approvals